Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1998-7-27
|
pubmed:abstractText |
Although vagus nerve stimulation (VNS) is now marketed throughout most of the world as a treatment for drug-resistant epilepsy, the therapeutic mechanism of action of VNS-induced seizure suppression has not yet been established. Elucidation of this mechanism is an important first step in the development of strategies to improve VNS efficacy. Because the locus coeruleus (LC) has been implicated in the antinociceptive effects of VNS, we chemically lesioned the LC in the present study to determine if it is a critical structure involved in the anticonvulsant mechanisms of VNS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0013-9580
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
709-14
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9670898-Animals,
pubmed-meshheading:9670898-Electric Stimulation Therapy,
pubmed-meshheading:9670898-Electroshock,
pubmed-meshheading:9670898-Female,
pubmed-meshheading:9670898-Hydroxydopamines,
pubmed-meshheading:9670898-Lidocaine,
pubmed-meshheading:9670898-Locus Coeruleus,
pubmed-meshheading:9670898-Norepinephrine,
pubmed-meshheading:9670898-Rats,
pubmed-meshheading:9670898-Rats, Sprague-Dawley,
pubmed-meshheading:9670898-Seizures,
pubmed-meshheading:9670898-Severity of Illness Index,
pubmed-meshheading:9670898-Vagus Nerve
|
pubmed:year |
1998
|
pubmed:articleTitle |
Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation.
|
pubmed:affiliation |
Neurology Service, West Los Angeles VA Medical Center, California 90073, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|